Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Irish Journal of Medical Science (1971 -)
Published in: Irish Journal of Medical Science (1971 -) 3/2016

01-08-2016 | Original Article

Diosgenin prevents bone loss on retinoic acid-induced osteoporosis in rats

Authors: S. Zhao, F. Niu, C.-Y. Xu, Y. Liu, L. Ye, G.-B. Bi, L. Chen, G. Tian, T.-H. Nie

Published in: Irish Journal of Medical Science (1971 -) | Issue 3/2016

Login to get access

Abstract

Objective

To observe the preventive and therapeutic effects of diosgenin on retinoic acid-induced osteoporosis in rats.

Methods

A total 50 Sprague-Dawley rats were randomly divided into 5 groups: control group, model group (osteoporosis rats), low (10 mg kg−1), middle (30 mg kg−1), and high-dose diosgenin (90 mg kg−1)-treated groups. The osteoporosis rats model was induced by retinoic acid. The BMD and physical parameters of femoral including length, wet weight, and dry weight in each group were measured. The hematoxylin–eosin staining was used for bone histomorphology analysis. Besides, the bone calcium (Ca) and phosphorus (P) contents were measured. In order to detect the biochemical index in different treatment groups, the serum tartrate-resistant acid phosphatase (TRAP), alkaline phosphatase (ALP), estradiol, and osteocalcin were compared among different groups.

Results

The osteoporosis rat model was successfully induced by retinoic acid. Compared with the model group, the lessening of femoral length and weight and the loss of BMD were significantly improved in diosgenin groups. Both contents of Ca and P were much more increased when induced by retinoic acid (p < 0.05). The estradiol and osteocalcin levels in the middle and high-dose treatment groups were significantly higher than that of the model group, while the ALP and TRAP levels were much lower than the model group (p < 0.05).

Conclusion

Diosgenin can prevent the loss of bone in experimental rats. The mechanism may be that it improves the level of estrogenic hormone of estradiol and inhibits the high bone turnover.
Literature
1.
Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9(8):1137–1141CrossRefPubMed
2.
Kanis J, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C, Delmas P, Eisman J, Johnell O, Jonsson B (2002) A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 13(7):527–536CrossRefPubMed
3.
Hodgson S, Watts N, Bilezikian J, Clarke B, Gray T, Harris D, Johnston C Jr, Kleerekoper M, Lindsay R, Luckey M (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 9(6):544CrossRefPubMed
4.
Ammann P, Rizzoli R (2003) Bone strength and its determinants. Osteoporos Int 14(3):13–18
5.
Wood AJ, Riggs BL, Melton LJ III (1992) The prevention and treatment of osteoporosis. N Engl J Med 327(9):620–627CrossRef
6.
Ueda H, Yamazaki C, Yamazaki M (2002) Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. Biol Pharm Bull 25(9):1197–1202CrossRefPubMed
7.
Gryglewski RJ, Korbut R, Robak J, Świȩs J (1987) On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol 36(3):317–322CrossRefPubMed
8.
Chiba H, Uehara M, Wu J, Wang X, Masuyama R, Suzuki K, Kanazawa K, Ishimi Y (2003) Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr 133(6):1892–1897PubMed
9.
Kim T-H, Jung JW, Ha BG, Hong JM, Park EK, Kim H-J, Kim S-Y (2011) The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss. J Nutr Biochem 22(1):8–15CrossRefPubMed
10.
Raju J, Patlolla JM, Swamy MV, Rao CV (2004) Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Cancer Epidemiol Biomark Prev 13(8):1392–1398
11.
Gupta A, Gupta R, Lal B (2001) Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. J Assoc Phys India 49:1057–1061
12.
Corbiere C, Liagre B, Bianchi A, Bordji K, Dauça M, Netter P, Beneytout J-L (2003) Different contribution of apoptosis to the antiproliferative effects of diosgenin and other plant steroids, hecogenin and tigogenin, on human 1547 osteosarcoma cells. Int J Oncol 22(4):899–906PubMed
13.
Liu M-J, Wang Z, Ju Y, Wong RN-S, Wu Q-Y (2005) Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis. Cancer Chemother Pharmacol 55(1):79–90CrossRefPubMed
14.
Higdon K, Scott A, Tucci M, Benghuzzi H, Tsao A, Puckett A, Cason Z, Hughes J (2001) The use of estrogen, DHEA, and diosgenin in a sustained delivery setting as a novel treatment approach for osteoporosis in the ovariectomized adult rat model. Biomed Sci Instrum 37:281PubMed
15.
Yen ML, Su JL, Chien CL, Tseng KW, Yang CY, Chen WF, Chang CC, Kuo ML (2005) Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts. Mol Pharmacol 68(4):1061–1073CrossRefPubMed
16.
Wu BXB, Huang T, Wang J (1996) A model of osteoporosis induced by retinoic acid in male Wistar rats. Acta Pharm Sin 31(4):241
17.
Wei MYZ, Li P, Zhang Y, Sse WC (2007) Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model. Am J Chin Med 35(04):663–667CrossRefPubMed
18.
Liao EY, Luo XH, Wang WB, Wu XP, Zhou HD, Dai RC, Liao HJ, Yang C (2003) Effects of different nylestriol/levonorgestrel dosages on bone metabolism in female Sprague-Dawley rats with retinoic acid-induced osteoporosis. Endocr Res 29(1):23–42CrossRefPubMed
19.
Xu P, Guo X, Zhang YG, Li YF, Cao JL, Xiong YM (2005) The effect of retinoic acid on induction of osteoporotic model rats and the possible mechanism. Sichuan Da Xue Xue Bao Yi Xue Ban 36:229–232PubMed
20.
Fahmy SR, Soliman AM (2009) Oxidative stress as a risk factor of osteoporotic model induced by vitamin A in rats. Aust J Basic Appl Sci 3:1559–1568
21.
Hough SAL, Muir H, Gelderblom D, Jenkins G, Kurasi H, Slatopolsky E, Bergfeld MA, Teitelbaum SL (1988) Effects of hypervitaminosis A on the bone and mineral metabolism of the rat. Endocrinology 122:2933–2939CrossRefPubMed
22.
Oršolić N, Goluža E, Đikić D, Lisičić D, Sašilo K, Rođak E, Jeleč Ž, Lazarus M, Orct T (2013) Role of flavonoids on oxidative stress and mineral contents in the retinoic acid-induced bone loss model of rat. Eur J Nutr 53:1217–1227. doi:10.​1007/​s00394-013-0622-7 PubMed
23.
Zhang Z, Song C, Fu X, Liu M, Li Y, Pan J, Liu H, Wang S, Xiang L, Xiao GG, Ju D (2014) High-dose diosgenin reduces bone loss in ovariectomized rats via attenuation of the RANKL/OPG ratio. Int J Mol Sci 15(9):17130–17147CrossRefPubMedPubMedCentral
24.
Price P, Parthemore J, Deftos L (1980) New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Investig 66(5):878CrossRefPubMedPubMedCentral
25.
Zhang Y, Yu L, Ao M, Jin W (2006) Effect of ethanol extract of Lepidium meyenii Walp. on osteoporosis in ovariectomized rat. J Ethnopharmacol 105(1):274–279CrossRefPubMed
26.
Zhang QYQL, Huang BK, Wang Y, Wang H, Chen L (2003) Effects and mechanisms of osthole on sciatica induced by lumber disc herniation. Chin Pharm J 5:101–104
27.
LE Bu SY, Frankin M, Marlow D, Brachett DJ, Boldrin EA (2007) Comparison of dried plum supplementation and intermittent PTH in restoring bone in osteopenic orchidectomized rats. Osteoporos Int 18:931–942CrossRefPubMed
28.
29.
Minkin C (1982) Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34(1):285–290CrossRefPubMed
30.
Deyhim F, Garica K, Lopez E, Gonzalez J, Ino S, Garcia M, Patil BS (2006) Citrus juice modulates bone strength in male senescent rat model of osteoporosis. Nutrition 22(5):559–563CrossRefPubMed
31.
Bharadwaj SNA, Betageri GV, Prasadarao NV, Naidu AS (2009) Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women. Osteoporos Int 20:1603–1611CrossRefPubMed
32.
Born AK, Lischer S, Maniura-Weber K (2012) Watching osteogenesis: life monitoring of osteogenic differentiation using an osteocalcin reporter. J Cell Biochem 113(1):313–321CrossRefPubMed
33.
Filip R, Possemiers S, Heyerick A, Pinheiro I, Raszewski G, Davicco MJ, Coxam V (2014) Twelve-month consumption of a polyphenol extract from olive (Olea europaea) in a double blind, randomized trial increases serum total osteocalcin levels and improves serum lipid profiles in postmenopausal women with osteopenia. J Nutr Health Aging 19:77–86. doi:10.​1007/​s12603-014-0480-x CrossRef
34.
Fernández-Real JM, Bulló M, Moreno-Navarrete JM, Ricart W, Ros E, Estruch R, Salas-Salvado J (2012) A Mediterranean diet enriched with olive oil is associated with higher serum total osteocalcin levels in elderly men at high cardiovascular risk. J Clin Endocrinol Metab 97(10):3792–3798CrossRefPubMedPubMedCentral
35.
Stepan JJPJ, Presl J (1987) Bone loss and biochemical indices of bone remodeling in surgically induced post-menopausal women. Bone 8:279–284CrossRefPubMed
36.
Ferretti M, Bertoni L, Cavani F, Benincasa M, Sena P, Carnevale G, Zavatti M, Di Viesti V, Zanoli P, Palumbo C (2012) Structural and histomorphometric evaluations of ferutinin effects on the uterus of ovariectomized rats during osteoporosis treatment. Life Sci 90(3):161–168CrossRefPubMed
37.
Rao LG, Krishnadev N, Banasikowska K, Rao AV (2003) Lycopene I—effect on osteoclasts: lycopene inhibits basal and parathyroid hormone-stimulated osteoclast formation and mineral resorption mediated by reactive oxygen species in rat bone marrow cultures. J Med Food 6(2):69–78CrossRefPubMed
38.
Mandadi K, Ramirez M, Jayaprakasha GK, Faraji B, Lihono M, Deyhim F, Patil BS (2009) Citrus bioactive compounds improve bone quality and plasma antioxidant activity in orchidectomized rats. Phytomedicine 16(6):513–520CrossRefPubMed
39.
Kono R, Okuno Y, K-i Inada, Tokuda A, Hashizume H, Yoshida M, Nakamura M, Utsunomiya H (2011) A Prunus mume extract stimulated the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biosci Biotechnol Biochem 75(10):1907–1911CrossRefPubMed
40.
Garrett I, Boyce B, Oreffo R, Bonewald L, Poser J, Mundy G (1990) Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Investig 85(3):632CrossRefPubMedPubMedCentral
41.
Shishodia S, Aggarwal B (2005) Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, IκB kinase activation and NF-κB-regulated gene expression. Oncogene 25(10):1463–1473CrossRef
Metadata
Title
Diosgenin prevents bone loss on retinoic acid-induced osteoporosis in rats
Authors
S. Zhao
F. Niu
C.-Y. Xu
Y. Liu
L. Ye
G.-B. Bi
L. Chen
G. Tian
T.-H. Nie
Publication date
01-08-2016
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 3/2016
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-015-1309-2

Other articles of this Issue 3/2016

Irish Journal of Medical Science (1971 -) 3/2016 Go to the issue

Original Article

Tumor suppression function of FoxD3 in lung cancer

Original Article

The importance of antenatal diagnosis of congenital duodenal obstruction

Original Article

Re-evaluating the role of Doppler ultrasonography in patients presenting with scrotal pain

Historical and Literary

The institutional response to mental disorder in Ireland: censuses of Irish asylums, psychiatric hospitals and units 1844–2014

Original Article

Readmission rates among cardiology inpatients with echocardiography abnormalities associated with heart failure

Original Article

Correction of vitamin D deficiency in a cohort of newborn infants using daily 200 IU vitamin D supplementation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits